Pamela M J McLaughlin
Overview
Explore the profile of Pamela M J McLaughlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
558
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McLaughlin P, Klar M, Zwimpfer T, Dutilh G, Vetter M, Marth C, et al.
BMC Cancer
. 2022 May;
22(1):508.
PMID: 35524184
Background: A high percentage of epithelial ovarian cancers (EOC) express the estrogen receptor (ER), which is an ideal target for endocrine therapy. Letrozole is a proven, potent aromatase inhibitor, extensively...
2.
Gerrits J, McLaughlin P, Nienhuis B, Smit J, Loef B
Clin Chem Lab Med
. 2012 Oct;
51(4):897-905.
PMID: 23045384
Background: Surface neutrophil CD64 expression is upregulated in patients with bacterial infection. As it was suggested that the CD64 index could be used to detect sepsis in hospitalized patients, we...
3.
van der Gun B, Melchers L, Ruiters M, de Leij L, McLaughlin P, Rots M
Carcinogenesis
. 2010 Sep;
31(11):1913-21.
PMID: 20837599
The epithelial cell adhesion molecule (EpCAM) is a membrane glycoprotein that is highly expressed on most carcinomas and therefore of potential use as a diagnostic and prognostic marker for a...
4.
van der Gun B, Maluszynska-Hoffman M, Kiss A, Arendzen A, Ruiters M, McLaughlin P, et al.
Bioconjug Chem
. 2010 Jul;
21(7):1239-45.
PMID: 20593890
The epithelial cell adhesion molecule (EpCAM) is a membrane glycoprotein that has been identified as a marker of cancer-initiating cells. EpCAM is highly expressed on most carcinomas, and transient silencing...
5.
McLaughlin P, Bakker A
Clin Chem Lab Med
. 2008 Jul;
46(6):878-9.
PMID: 18601615
No abstract available.
6.
Trzpis M, Bremer E, McLaughlin P, de Leij L, Harmsen M
Front Biosci
. 2008 May;
13:5050-5.
PMID: 18508569
Embryonic development is one of the most complex biological phenomena that involves the appropriate expression and synchronized interactions of a plethora of proteins, including cell adhesion molecules (CAMs). Many members...
7.
van der Gun B, Wasserkort R, Monami A, Jeltsch A, Rasko T, Slaska-Kiss K, et al.
Int J Cancer
. 2008 Apr;
123(2):484-489.
PMID: 18398839
The epithelial cell adhesion molecule (EpCAM) is expressed at high levels on the surface of most carcinoma cells. SiRNA silencing of EpCAM expression leads to reduced metastatic potential of tumor...
8.
Trzpis M, Popa E, McLaughlin P, Goor H, Timmer A, Bosman G, et al.
Nephron Exp Nephrol
. 2007 Nov;
107(4):e119-31.
PMID: 18025791
Background: The epithelial cell adhesion molecule (EpCAM) is expressed by most epithelia and is involved in processes fundamental for morphogenesis, including cell-cell adhesion, proliferation, differentiation, and migration. Previously, a role...
9.
van der Gun B, Monami A, Laarmann S, Rasko T, Slaska-Kiss K, Weinhold E, et al.
J Control Release
. 2007 Sep;
123(3):228-38.
PMID: 17884225
Cationic liposomal compounds are widely used to introduce DNA and siRNA into viable cells, but none of these compounds are also capable of introducing proteins. Here we describe the use...
10.
Kosterink J, McLaughlin P, Lub-de Hooge M, Hendrikse H, van Zanten J, van Garderen E, et al.
J Immunol
. 2007 Jul;
179(2):1362-8.
PMID: 17617629
The human pancarcinoma-associated epithelial cell adhesion molecule (EpCAM) (EGP-2, CO17-1A) is a well-known target for carcinoma-directed immunotherapy. Mouse-derived mAbs directed to EpCAM have been used to treat colon carcinoma patients...